152 related articles for article (PubMed ID: 25753145)
21. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
[TBL] [Abstract][Full Text] [Related]
22. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
23. Osteopontin expression in gestational trophoblastic diseases: correlation with expression of the adhesion molecule, CEACAM1.
Briese J; Oberndörfer M; Schulte HM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2005 Jul; 24(3):271-6. PubMed ID: 15968204
[TBL] [Abstract][Full Text] [Related]
24. Differential expression patterns of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) -1, -4, -5, and -14 in human placenta and gestational trophoblastic diseases.
Lee SY; Lee HS; Gil M; Kim CJ; Lee YH; Kim KR; Park CS
Arch Pathol Lab Med; 2014 May; 138(5):643-50. PubMed ID: 24786121
[TBL] [Abstract][Full Text] [Related]
25. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
[TBL] [Abstract][Full Text] [Related]
26. Expression pattern of the cell cycle promoter cyclin e in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67.
Bamberger AM; Aupers S; Milde-Langosch K; Löning T
Int J Gynecol Pathol; 2003 Apr; 22(2):156-61. PubMed ID: 12649670
[TBL] [Abstract][Full Text] [Related]
27. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations.
Shih IM; Kurman RJ
Am J Surg Pathol; 2004 Sep; 28(9):1177-83. PubMed ID: 15316317
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
[TBL] [Abstract][Full Text] [Related]
29. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.
Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z
Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643
[TBL] [Abstract][Full Text] [Related]
30. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
31. p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases.
Shoni M; Nagymanyoki Z; Vitonis AF; Jimenez C; Ng SW; Quade BJ; Berkowitz RS
Gynecol Oncol; 2013 Dec; 131(3):759-63. PubMed ID: 24051221
[TBL] [Abstract][Full Text] [Related]
32. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN
Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985
[TBL] [Abstract][Full Text] [Related]
33. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast.
Crescimanno C; Marzioni D; Paradinas FJ; Schrurs B; Mühlhauser J; Todros T; Newlands E; David G; Castellucci M
J Pathol; 1999 Dec; 189(4):600-8. PubMed ID: 10629564
[TBL] [Abstract][Full Text] [Related]
34. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
Lei ZM; Rao CV; Ackerman DM; Day TG
J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
36. The role of GATA3 in breast carcinomas: a review.
Asch-Kendrick R; Cimino-Mathews A
Hum Pathol; 2016 Feb; 48():37-47. PubMed ID: 26772397
[TBL] [Abstract][Full Text] [Related]
37. PD-L1 in gestational trophoblastic disease: an antibody evaluation.
Hoeijmakers YM; Simons M; Bulten J; Gorris MAJ; Ottevanger PB; de Vries IJM; Sweep FCGJ
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):1007-1016. PubMed ID: 35689468
[TBL] [Abstract][Full Text] [Related]
38. [Potential role of the angiogenic factor "EG-VEGF" in gestational trophoblastic diseases].
Boufettal H; Feige JJ; Benharouga M; Aboussaouira T; Nadifi S; Mahdaoui S; Samouh N; Alfaidy N
Pathol Biol (Paris); 2013 Oct; 61(5):178-83. PubMed ID: 23647696
[TBL] [Abstract][Full Text] [Related]
39. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
40. The pathology of gestational trophoblastic disease: recent advances.
Wells M
Pathology; 2007 Feb; 39(1):88-96. PubMed ID: 17365825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]